Wang Qiuyi, Yao Xueming, Ling Yi, Huang Ying, Chen Changming, Hou Lei, Yang Yutao, Wu Hongyan, Ma Wukai
Clinical Medical College, Jiangxi University of Traditional Chinese Medicine, Nanchang 330000, China.
Department of Rheumatology and Immunology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550001, China.
Evid Based Complement Alternat Med. 2022 Jul 5;2022:2993374. doi: 10.1155/2022/2993374. eCollection 2022.
Schltr () is an edible medicinal herb with various health benefits such as treating antirheumatoid arthritis (RA), reducing inflammation, and preventing tumor growth. The active ingredients in responsible for its protective effect against RA, however, remain unknown. In this study, the active ingredient of and its potential mechanism of action against RA were investigated by network pharmacology and enrichment analysis. The methods included predicting target genes of P. forrestii, constructing a protein interaction network, and performing gene-ontology (GO) and Kyoto-encyclopedia of genes and genomes (KEGG) enrichment analysis. We discovered targets of RA through retrieval of OMIM and GeneCards public databases. Cardiac glycosides (CGs) are considered the primarily active ingredients of , and the target genes of GCs were discovered to be overlapped with relevant targets of RA using the Venn diagram. After that, prediction of relevant targets of P. forrestii was accomplished with a network pharmacology-based approach. Through the Venn diagram, we discovered 99 genes shared in the target genes of and RA. Gene enrichment analysis showed that the mechanisms of CGs against RA are associated with 55 signaling pathways, including endocrine resistance, Epstein-Barr virus infection, bladder cancer, prostate cancer, and coronavirus disease (COVID-19) signaling pathways. Coexpression analysis indicated ADSL, ATIC, AR, CCND1, MDM2, and HSP90AA1 as the hub genes between putative targets of -derived CGs and known therapeutic targets of RA. In conclusion, we clarified the mechanism of action of against RA, which would provide a basis for further understanding the clinical application of
Schltr()是一种可食用的药草,具有多种健康益处,如治疗类风湿性关节炎(RA)、减轻炎症和预防肿瘤生长。然而,其对RA具有保护作用的活性成分仍不清楚。在本研究中,通过网络药理学和富集分析研究了Schltr()的活性成分及其抗RA的潜在作用机制。方法包括预测Forrestii的靶基因、构建蛋白质相互作用网络以及进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析。我们通过检索OMIM和GeneCards公共数据库发现了RA的靶点。强心苷(CGs)被认为是Schltr()的主要活性成分,使用维恩图发现GCs的靶基因与RA的相关靶点重叠。之后,采用基于网络药理学的方法完成了Schltr()相关靶点的预测。通过维恩图,我们发现Schltr()和RA的靶基因中有99个基因共享。基因富集分析表明,CGs抗RA的机制与55条信号通路相关,包括内分泌抵抗、爱泼斯坦-巴尔病毒感染、膀胱癌、前列腺癌和冠状病毒病(COVID-19)信号通路。共表达分析表明ADSL、ATIC、AR、CCND1、MDM2和HSP90AA1是Schltr()衍生CGs的假定靶点与RA已知治疗靶点之间的枢纽基因。总之,我们阐明了Schltr()抗RA的作用机制,这将为进一步理解其临床应用提供依据。